Re: Failure-Free Survival and Radiotherapy in Patients with Newly Diagnosed Nonmetastatic Prostate Cancer: Data from Patients in the Control Arm of the STAMPEDE Trial. [electronic resource]
- European urology 08 2016
- 398-9 p. digital
Publication Type: Journal Article; Comment
1873-7560
10.1016/j.eururo.2016.03.065 doi
Androgen Antagonists Humans Male Prostatic Neoplasms